Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Jue Yeon Lee"'
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2473
Multiple myeloma (MM) is the second most common hematological malignancy. It is a clonal B-cell disorder characterized by the proliferation of malignant plasma cells in the bone marrow, the presence of monoclonal serum immunoglobulin, and osteolytic
Autor:
Yoon Jeong Park, Gookjin Yoon, Jinsook Suh, Beom Soo Jo, Dong Woo Lee, Deogil Kim, Moonsil Choi, Eui Kyun Jeong, Hoo Cheol Lee, Jue-Yeon Lee, Chong Pyung Chung, Yoon Shin Park
The RAS-RAF-ERK1/2 pathway is a crucial target for anticancer drug development because of the high prevalence of ERK activation in human cancers. Mitogen-activated protein kinases (MAPKs) are pivotal intracellular cascade molecules critical in all eu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64d964586a9ceb21307c7064a216b035
https://doi.org/10.21203/rs.3.rs-2394020/v1
https://doi.org/10.21203/rs.3.rs-2394020/v1
Autor:
Kwang-Sook Park, Yoon Jeong Park, Beom Soo Jo, Dong Woo Lee, Chong Pyung Chung, Yoon Shin Park, Jue-Yeon Lee
Publikováno v:
Journal of Biomedical Materials Research Part A. 109:2001-2016
Various biomaterials have been used for bone and cartilage regeneration, and inflammation associated with biomaterial implantation is also increased. A 15-mer synthetic anti-inflammatory peptide (SAP15) was designed from human β-defensin 3 to penetr
Autor:
Gookjin Yoon, Beom Soo Jo, Dong Woo Lee, Jinwook Yang, Min-Ho Park, Sanghui Seok, Jue Yeon Lee, Chong Pyoung Chung, Yoon Shin Park, Yoon Jeong Park
Publikováno v:
Molecular Cancer Research. 21:B039-B039
Activation of mutations in RAS has been found in high ratio in human cancers, inducing downstream critical effectors corresponding tumorigenesis. In recent years, RAS-RAF-ERK1/2 pathway is known as a crucial target for the anti-cancer drug developmen
Autor:
Gookjin Yoon, Beom Soo Jo, Dong Woo Lee, Jinwook Yang, Min-Ho Park, Sanghui Seok, Jue-Yeon Lee, Chong Pyung Chung, Yoon Jeong Park
Publikováno v:
Cancer Research. 83:569-569
Activation of mutations in RAS has been found in high ratio in human cancers, inducing downstream critical effectors corresponding tumorigenesis. The attempts in direct targeting to activated RAS, which is GTP bound, has been somewhat successful in t
Publikováno v:
Molecular & Cellular Toxicology. 15:245-254
Backgrounds: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. However, little is known about the molecular mechanisms of HCC development, progression, or effective therapeutic approaches. Recently, granulin-epithelin precurso
Autor:
Da Hyeon Choi, Jue Yeon Lee, Inho Jo, Jong Chul Park, Si Min Lee, Yoon Jeong Park, Yoon Shin Park, Kyeong Eun Lee, Ki Dong Park, Beom Soo Jo, Se Young Oh
Publikováno v:
Biomaterials. 278
Controlling the senescence of mesenchymal stem cells (MSCs) is essential for improving the efficacy of MSC-based therapies. Here, a model of MSC senescence was established by replicative subculture in tonsil-derived MSCs (TMSCs) using senescence-asso
Autor:
Da Hyeon Choi, Kyeong Eun Lee, Beom Soo Jo, Jue-Yeon Lee, Kwang-Sook Park, Yoon Jeong Park, Ju Kwang Choi, Yoon Shin Park, Dong Woo Lee
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 4251, p 4251 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 12
International Journal of Molecular Sciences
Volume 21
Issue 12
We report dual therapeutic effects of a synthetic heparin-binding peptide (HBP) corresponding to residues 15&ndash
24 of the heparin binding site in BMP4 in a collagen-induced rheumatic arthritis model (CIA) for the first time. The cell penetrat
24 of the heparin binding site in BMP4 in a collagen-induced rheumatic arthritis model (CIA) for the first time. The cell penetrat
Publikováno v:
Annals of physical and rehabilitation medicine. 64(3)
Background Individuals with cerebral palsy (CP) experience bone loss due to impaired weight bearing. Despite serious complications, there is no standard medication. Objective To develop a new pharmacological agent, we performed a series of studies. T
Autor:
Deogil Kim, Dong Woo Lee, Eui Kyun Jeong, Hoo Cheol Lee, Yoon Shin Park, Jue Yeon Lee, Chong Pyung Chung, Yoon Jeong Park
Publikováno v:
Gastroenterology. 162:S64
Under Inflammatory bowel disease (IBD), impaired intestinal barrier from lumen is highly associated with ongoing IBD symptoms and it also contributes as a precursor for IBD. Current IBD therapeutics lack on mucosal regeneration, which the unmet needs